✦ LIBER ✦

Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus

✍ Scribed by Curtis Triplitt; Alison Wright; Elaine Chiquette

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl Peptidase IV Inhibitors and t

✍ Alissa K. Langley; Terri J. Suffoletta; Heath R. Jennings 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Dipeptidyl peptidase IV inhibitors for t

✍ Paul E. Wiedeman; James M. Trevillyan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Novel therapeutics for type 2 diabetes:

✍ E.J. Verspohl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 913 KB

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Dr. Joshua J. Neumiller; Dr. Lindy Wood; Mr. R. Keith Campbell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Incretin Mimetics and DPP-IV Inhibitors:

✍ Hinnen, D.; Nielsen, L. L.; Waninger, A.; Kushner, P. 📂 Article 📅 2006 🏛 American Board of Family Medicine 🌐 English ⚖ 102 KB

Incretin mimetics and DPP-IV inhibitors

✍ Loretta L. Nielsen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 154 KB